ATLANTA, Sept. 23, 2021 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of innovative health research, services, and solutions to federal agencies, today announced that it has been awarded a contract to provide medical countermeasures and emergency medical services for hospitals, long-term care facilities, and schools throughout Alaska as the state responds to an increase in COVID-19 cases.
Under a Federal Emergency Management Agency (“FEMA”) contract to provide support for states seeking temporary hospital support during the COVID-19 pandemic, this competitively awarded contract for Alaska has a ceiling value of $87 million for the 90-day base period. It provides for three one-month optional extensions after the initial period of performance. As the prime contractor, DLH will manage the emergency medical logistics coordination for the healthcare services teams fielded by its subcontractor, which will provide a significant percentage of the services.
“DLH is proud to build upon our role in support of the national response to the COVID-19 pandemic,” said Kevin Wilson, president of DLH’s Health & Logistics Services operating unit. “DLH will work rapidly to provide support for Alaska’s world-class health professionals with the accountability, safety, and efficiency our customers and their patients have come to expect.”
Under this contract, DLH will leverage its relationship with a nationally recognized temporary medical staffing firm to place experienced medical support personnel in communities throughout the state. These highly-trained medical professionals will augment existing healthcare staff, supporting around the clock coverage to counter the COVID-19 pandemic.
“From the onset of our nation’s battle against this pandemic, DLH has been at the forefront of the scientific, medical, and operational response,” added Zach Parker, President and CEO of DLH. “We have implemented innovative approaches to reach patients in rural and remote areas, with the aim of ensuring all Americans have access to the care they need. Now, as our fellow Americans face another wave of this disease, DLH will work with urgency and agility to provide high-quality medical support.”
About DLH
DLH delivers improved health and readiness solutions for federal programs through research, development, and innovative care processes. The Company’s experts in public health, performance evaluation, and health operations solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With over 2,200 employees dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of government sector experience, proven methodology, and unwavering commitment to public health to improve the lives of millions. For more information, visit www.DLHcorp.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s future financial performance. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements in this release include, among others, statements regarding estimates of future revenues, operating income, earnings and cash flow. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Our actual results may differ materially from such forward-looking statements made in this release due to a variety of factors, including: the outbreak of the novel coronavirus (“COVID-19”), including the measures to reduce its spread, and its impact on the economy and demand for our services, are uncertain, cannot be predicted, and may precipitate or exacerbate other risks and uncertainties; the risk that we will not realize the anticipated benefits of our recent or any future acquisition; the challenges of managing larger and more widespread operations resulting from our recent acquisition; contract awards in connection with re-competes for present business and/or competition for new business; compliance with new bank financial and other covenants; changes in client budgetary priorities; government contract procurement (such as bid and award protests, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; the ability to successfully integrate the operations our recent acquisition and of any future acquisitions; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2020, as well as subsequent reports filed thereafter. The forward-looking statements contained herein are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business. Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements, except as may be required by law.
CONTACT:
